KRYS   $113.28  -3.30% Market Closed

Krystal Biotech Inc
Total Cash 532.18M
totalCashPerShare 18.81
EBITDA -92.22M
Total Debt 8.09M
quickRatio 17.351
currentRatio 17.765
Total Revenue 50.70M
debtToEquity 1.04
Revenue/Share 1.867
ROA -0.08826999
ROE 0.01681
grossProfits
freeCashflow -74.41M
operatingCashflow -88.80M
earningsGrowth
revenueGrowth
grossMargins 0.93897
ebitdaMargins -1.8189701
operatingMargins 0.07446
profitMargins 0.21563
enterpriseValue 4.49B
forwardPE 44.15136
floatShares 20.43M
sharesOutstanding 28.29M
sharesShort 2.24M
sharesShortPriorMonth 2.47M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.90%
Short Ratio help_outline 3.71%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 27.576
Price To Book help_outline 6.45
earningsQuarterlyGrowth
netIncomeToCommon 10.93M
trailingEps 0.39%
forwardEps 4.03%
enterpriseToEbitda -48.68
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.02 1Q 2024
institutionsCount 291
lastUpdated April 1, 2024, 2:33 p.m.